Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2020 Oct 29

PMID 33114612

Citations 11

Authors

Jonathan Kerr

Affiliations

Soon will be listed here.

Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic multisystem disease exhibiting a variety of symptoms and affecting multiple systems. Psychological stress and virus infection are important. Virus infection may trigger the onset, and psychological stress may reactivate latent viruses, for example, Epstein-Barr virus (EBV). It has recently been reported that EBV induced gene 2 (EBI2) was upregulated in blood in a subset of ME/CFS patients. The purpose of this study was to determine whether the pattern of expression of early growth response (EGR) genes, important in EBV infection and which have also been found to be upregulated in blood of ME/CFS patients, paralleled that of EBI2. EGR gene upregulation was found to be closely associated with that of EBI2 in ME/CFS, providing further evidence in support of ongoing EBV reactivation in a subset of ME/CFS patients. EGR1, EGR2, and EGR3 are part of the cellular immediate early gene response and are important in EBV transcription, reactivation, and B lymphocyte transformation. EGR1 is a regulator of immune function, and is important in vascular homeostasis, psychological stress, connective tissue disease, mitochondrial function, all of which are relevant to ME/CFS. EGR2 and EGR3 are negative regulators of T lymphocytes and are important in systemic autoimmunity.

Citing Articles

Manual Therapy Improves Fibromyalgia Symptoms by Downregulating .

Bonastre-Ferez J, Gimenez-Orenga K, Falaguera-Vera F, Garcia-Escudero M, Oltra E Int J Mol Sci. 2024; 25(17).

PMID: 39273470 PMC: 11394909. DOI: 10.3390/ijms25179523.

Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.

Domingo J, Battistini F, Cordobilla B, Zaragoza M, Sanmartin-Sentanes R, Alegre-Martin J J Transl Med. 2024; 22(1):343.

PMID: 38600563 PMC: 11005215. DOI: 10.1186/s12967-024-05148-0.

Reactivation of Epstein-Barr virus in SFTSV infected patients.

Fang L, Dong Y, Yan Z, Zhou C, Yu X, Qin X Infect Med (Beijing). 2023; 2(3):195-201.

PMID: 38073887 PMC: 10699715. DOI: 10.1016/j.imj.2023.04.005.

Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Maya J Int J Mol Sci. 2023; 24(15).

PMID: 37569313 PMC: 10418326. DOI: 10.3390/ijms241511937.

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.

Bonilla H, Peluso M, Rodgers K, Aberg J, Patterson T, Tamburro R Front Immunol. 2023; 14:1129459.

PMID: 36969241 PMC: 10034329. DOI: 10.3389/fimmu.2023.1129459.

References

Thorley-Lawson D, Miyashita E, Khan G . Epstein-Barr virus and the B cell: that's all it takes. Trends Microbiol. 1996; 4(5):204-8. DOI: 10.1016/s0966-842x(96)90020-7. View

Zhu B, Symonds A, Martin J, Kioussis D, Wraith D, Li S . Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J Exp Med. 2008; 205(10):2295-307. PMC: 2556781. DOI: 10.1084/jem.20080187. View

Kim J, Kim W, Kang J, Lim H, Ko Y, Park C . Egr-1, a new downstream molecule of Epstein-Barr virus latent membrane protein 1. FEBS Lett. 2007; 581(4):623-8. DOI: 10.1016/j.febslet.2007.01.020. View

Kehrl J, Thevenin C, Rieckmann P, Fauci A . Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol. 1991; 146(11):4016-23. View

Zheng Y, Zha Y, Driessens G, Locke F, Gajewski T . Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo. J Exp Med. 2012; 209(12):2157-63. PMC: 3501351. DOI: 10.1084/jem.20120342. View

Scheibenbogen C, Loebel M, Freitag H, Krueger A, Bauer S, Antelmann M . Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME. PLoS One. 2018; 13(3):e0193672. PMC: 5854315. DOI: 10.1371/journal.pone.0193672. View

Gutsch D, Zhang Q, Stein B, Blanar M, Baldwin A, Kenney S . The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B. Mol Cell Biol. 1994; 14(3):1939-48. PMC: 358552. DOI: 10.1128/mcb.14.3.1939-1948.1994. View

McMahon S, Monroe J . The role of early growth response gene 1 (egr-1) in regulation of the immune response. J Leukoc Biol. 1996; 60(2):159-66. DOI: 10.1002/jlb.60.2.159. View

Watanabe Y, Stone E, McEwen B . Induction and habituation of c-fos and zif/268 by acute and repeated stressors. Neuroreport. 1994; 5(11):1321-4. View

10.

Cheval H, Chagneau C, Levasseur G, Veyrac A, Faucon-Biguet N, Laroche S . Distinctive features of Egr transcription factor regulation and DNA binding activity in CA1 of the hippocampus in synaptic plasticity and consolidation and reconsolidation of fear memory. Hippocampus. 2011; 22(3):631-42. DOI: 10.1002/hipo.20926. View

11.

Levkovitz Y, Baraban J . A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex. J Neurosci. 2002; 22(10):3845-54. PMC: 6757642. DOI: 20026370. View

12.

Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L . Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res. 2007; 97:81-109. DOI: 10.1016/S0065-230X(06)97004-3. View

13.

Kumar K, Li L, Yan M, Bhaskarabhatla M, Mobley A, Nguyen C . Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science. 2006; 312(5780):1665-9. DOI: 10.1126/science.1125893. View

14.

Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W . The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 2000; 19(12):3080-9. PMC: 203345. DOI: 10.1093/emboj/19.12.3080. View

15.

Bahrami S, Drablos F . Gene regulation in the immediate-early response process. Adv Biol Regul. 2016; 62:37-49. DOI: 10.1016/j.jbior.2016.05.001. View

16.

Warner L, Mancias P, Butler I, McDonald C, Keppen L, Koob K . Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet. 1998; 18(4):382-4. DOI: 10.1038/ng0498-382. View

17.

Hamlin A, McNally G, Osborne P . Induction of c-Fos and zif268 in the nociceptive amygdala parallel abstinence hyperalgesia in rats briefly exposed to morphine. Neuropharmacology. 2007; 53(2):330-43. DOI: 10.1016/j.neuropharm.2007.05.017. View

18.

Cohen S, Tyrrell D, Smith A . Psychological stress and susceptibility to the common cold. N Engl J Med. 1991; 325(9):606-12. DOI: 10.1056/NEJM199108293250903. View

19.

Heather J, Flower K, Isaac S, Sinclair A . The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1. J Gen Virol. 2009; 90(Pt 6):1450-1454. PMC: 2885059. DOI: 10.1099/vir.0.007922-0. View

20.

Sumitomo S, Fujio K, Okamura T, Yamamoto K . Egr2 and Egr3 are the unique regulators for systemic autoimmunity. JAKSTAT. 2013; 2(2):e23952. PMC: 3710327. DOI: 10.4161/jkst.23952. View